pig ileum; LAP, leucine aminopeptidase Two ml of the digest (30 mg W ml) was put on the column. Opioid activity was detected in the fractions indicated by arrows. Opioid peptide hemorphin-5 (YPWTQ) was released from human hemoglobin by the action of pancreatic elastase. V-hemorphin-5 (VYPWTQ) was also released under the same conditions. The amount of hemorphin-5 was about 1 W 10 that of V-hemorphin-5. This is theˆrst report showing release of hemorphin-5 only by the action of one enzyme.
Hemorphin-4 (YPWT) and -5 (YPWTQ) are opioid peptides isolated by Brantl et al. from enzymatically digested blood. 1, 2) Although pharmacological studies on hemorphin-4 and -5 have been done, enzymes responsible for their release have not been identiˆed yet.
In our previous paper we reported that pancreatic elastase (PE) had an important role in the release of b-casomorphin-7 (YPFPGPI) from bovine b-casein.
3)
PE gave V-b-casomorphin-7 (VYPFPGPI), of which the opioid activity is about 1 W 10 that of b-casomorphin, by cleaving the peptide bond between Leu 59 -Val 60 and Ile 67 -His 68 . Leucine aminopeptidease (LAP) was required to remove valine to obtain b-casomorphin-7 (YPFPGPI). We noticed that the amino acid sequence preceding hemorphin (LVVYPW-) has similarity to that of b-casomorphin (LVYPF-). In this study we hydrolyzed hHb by PE and analyzed hemorphin-related peptides in the digest.
Thirty mg W ml of hHb (Sigma) dissolved in water was digested at pH 8 by PE (E W S＝1 W 100 (wt W wt)) (Elastin Products) for 5 h at 379 C with occasional pH adjustment with 1 M NaOH. The digest was fractionated by RP-HPLC using ODS (20×250 mm) column with a linear gradient of acetonitrile (0-40z W 40 min), containing 0.1z TFA at a ‰ow rate of 10 ml W min, and the active fractions were further puriˆed on phenetyl (4.6×250 mm) and cyanopropyl (4.6×250 mm) (Nacalai Tesque Inc.) columns at ‰ow rates of 1 ml W min. The structure of peptides were analyzed by a 477A protein sequencer (Applied Biosystems) and molecular masses were measured by LC-MS (Applied Biosystems). Opioid activity was measured by the guinea pig ileum (GPI) assay. 4) Two opioid active fractions (A and B) were obtained after fractionation of a PE digest of hHb by HPLC on an ODS column (Fig. 1) . From fraction A, we obtained an opioid active peptide after puriˆca-tion by HPLC on phenetyl and cyanopropyl columns with retention times of 32.5 min and 16.3 min, respectively. The structure of the peptide was YPWTQ, which is well-known as hemorphin-5. The opioid peptide isolated from fraction B had a retention time of 33.8 min and 17.0 min on phenetyl and 3) Generally, PE hydrolyzes peptide bond formed by neutral nonaromatic amino acid residues such as alanine, serine, glycine, and valine. The reason why PE could not hydrolyze Val-Tyr bond in b-casein while it hydrolyzed the same bond in hemoglobin is unclear.
Many reports showed release of LVV-hemorphin-7, VV-hemorphin-7, VV-hemorphin-6, LVV-hemorphin-5, VV-hemorphin-5, and VV-hemorphin-4 from hemoglobin by the action of pepsin, catepsin D, endogenous lysosomal proteases, and peritoneal macrophages in vitro. [5] [6] [7] [8] [9] [10] [11] In these cases, intestinal LAP is required to remove Leu and Val residues from amino terminus of these peptides. In this study we showed for theˆrst time release of hemorphin-5 only by the action of PE.
In recent years hemorphin-related peptides were also detected in vivo: bovine brain, bronchoalveolar lavage ‰uid of patients with adenocarcinoma of the lung, blood plasma during long distance running, and cerebrospinal ‰uid from patients with cerebrovascular bleeding. [12] [13] [14] [15] At their targets the hemorphins could bind to the opioid receptor to mediate a wide spectra of biological functions such as analgesia, cardiovascular eŠect, gastrointestinal activity, behaviour, and eŠects on endocrine system. 16, 17) We also hydrolysed hHb with leucocyte elastase and recovered traces of hemorphin-5 in the digest (data not shown). Further study will be required to clarify whether these elastases or related enzymes are responsible for the release of hemorphin-5 in vivo.
